Latest News
-

September 2026: This month in Huntington’s disease research
⏱️ 5 min read
September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, and encouraging SKY-0515 data, we round up a busy month in Huntington’s disease research.
-

CHDI Report: Day 1
⏱️ 9 min read
Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
-

Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way
⏱️ 4 min read
Anti-nausea drug meclizine protects cells with the HD mutation from death by reducing cellular energy production
-

HDBuzz takes your questions to the annual therapeutics meeting of CHDI
⏱️ 4 min read
HDBuzz visits Palm Springs to talk with CHDI about the latest HD research. Send us your questions!
-

Welcome to HDBuzz
⏱️ 3 min read
Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co
-

Memantine in HD: dose is everything
⏱️ 4 min read
Memantine, a drug already used in Alzheimer’s disease, might help in HD, but a mouse study shows dose is everything.
-

An active lifestyle may make a difference to HD symptoms
⏱️ 4 min read
More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.
-

Frequently asked questions, January 2011
⏱️ 5 min read
Answers to frequently-asked questions about HD – the first in a regular series of HDBuzz FAQ articles.
-

Getting the data out – a new scientific journal just for HD
⏱️ 4 min read
New scientific journal PLoS Currents HD promises rapid publication & open access, improving scientific communication
-

Dimebon: disappointing in Alzheimer’s but might work in HD
⏱️ 3 min read
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.
-

Does HD cause brains to develop differently?
⏱️ 4 min read
Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
-
Food for Thought: The Importance of Nutrition in Huntington’s Disease
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
